Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen forHelicobacter pylorieradication: A pilot study-Reference-Cited by-同舟云学术

Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen forHelicobacter pylorieradication: A pilot study

Published:2015-11-13 Issue:3 Volume:4 Page:380-387
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:United European Gastroenterology Journal

Author:

Mori Hideki¹,Suzuki Hidekazu¹²,Matsuzaki Juntaro¹,Tsugawa Hitoshi³,Fukuhara Seiichiro¹,Miyoshi Sawako¹,Hirata Kenro¹,Seino Takashi¹,Matsushita Misako¹,Nishizawa Toshihiro¹,Masaoka Tatsuhiro¹,Kanai Takanori¹

Affiliation:

1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

2. Medical Education Center, Keio University School of Medicine, Tokyo, Japan

3. Department of Biochemistry and Integrative Medical Biology, Keio University School of Medicine, Tokyo, Japan

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

http://journals.sagepub.com/doi/pdf/10.1177/2050640615618043

Reference28 articles.

1. Recurrent Peptic Ulcers in Patients Following Successful Helicobacter pylori Eradication: A Multicenter Study of 4940 Patients

2. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

3. Long-term clinical outcome of gastric MALT lymphoma after eradication ofHelicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan

4. A Multicenter, Double-Blind Study on Triple Therapy with Lansoprazole, Amoxicillin and Clarithromycin for Eradication of Helicobacter pylori in Japanese Peptic Ulcer Patients

5. Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-Arm, Prospective, Interventional Study of Helicobacter pylori Eradication Rescue Therapy with Rifabutin, Metronidazole, and Vonoprazan;Journal of Clinical Medicine;2024-06-27

2. Safety, pharmacokinetics, and efficacy of rifasutenizol, a novel dual-targeted antibacterial agent in healthy participants and patients in China with Helicobacter pylori infection: four randomised clinical trials;The Lancet Infectious Diseases;2024-06

3. Antibiotic Resistance of Helicobacter pylori: Mechanisms and Clinical Implications;Journal of Korean Medical Science;2024

4. Effectiveness of Rifabutin-Based Regimens in Treating Helicobacter pylori Infections;Cureus;2023-12-14

5. Rifabutin-Containing Triple Therapy Versus Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter, Randomized Controlled Trial;The Journal of Infectious Diseases;2023-04-20